T-Lymphocyte Subsets in the Embryonic Spleen Undergoing a Graft-Versus-Host Reaction by Fedecka-Bruner, Barbara et al.
Developmental Immunology, 1991, Vol. 1, pp. 163-168
Reprints available directly from the publisher
Photocopying permitted by license only
1991 Harwood Academic Publishers GmbH
Printed in the United Kingdom
T-Lymphocyte Subsets in the Embryonic Spleen
Undergoing a Graft-Versus-Host Reaction
BARBARA FEDECKA-BRUNER*, PIERRE VAIGOT, JACQUELINE DISVEAUX-CHABROL,
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Allogeneic immunocompetent T cells injected into chicken embryos induce a graft-versus-
host reaction (GVHR) whose most prominent manifestation is splenic hyperplasia. The
highly inbred CC and CB strains of chickens used here are, respectively, homozygous for
the B4 or B12 MHC haplotypes. By means of a panel of immunological reagents, including
alloantisera and monoclonal antibodies against public domains of the T-cell receptor, CD4,
CD8, and the inducible interleukin-2-receptor light chain (CD25), it is shown that the bulk
of cells in the enlarged spleen are of host origin and do not express markers typical of
mature T or B lymphocytes. Among recipient splenocytes, the quantitatively most important
population consists of TCRa-TCRy6-CD4-CD8/CD25 (TCR0) lymphocytes. Donor cells
encountered in the spleen prevalently exhibit a TCRc/+CD4+CD8-CD25+ phenotype and
proliferate in vivo. The data demonstrate that nonspecific host and potentially specific donor-
derived cellular elements contribute to splenomegaly.
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INTRODUCTION
The development of graft-versus-host reactions
(GVHR) depends on a special set of requirements
each of which has the status of conditio sine qua non
(for a review, see Bril and Benner, 1985; Parkman,
1989). First, graft and host have to differ in major or
minor histocompatibility loci. Second, the allograft
must contain immunologically competent allore-
active T cells. Third, the recipient needs to be
immunodeficient, thus being incapable of rapidly
eliminating the grafted cells by an immunological
counterattack (host-versus-graft reaction). GVHR is
a major complication of therapeutic bone marrow
transplantation in patients and may become mani-
fest in an acute or chronic fashion, then mimicking
certain aspects of autoimmune diseases. Much of the
pioneering work on GVHR has been performed in
the chicken embryo, where it is induced either by
placing immunocompetent allogeneic T cells onto
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the chorioallantoic membrane or by injecting them
intravenously (Simonsen, 1957, 1962; Seto and
Albright, 1965; D6sveaux-Chabrol and Dieterlen-
Li/vre, 1987; D(sveaux-Chabrol et al., 1989). The
latter procedure entails a systemic response whose
most spectacular manifestation is splenomegaly, that
is, an easily quantifiable increase of splenic mass.
Extensive studies have been carried out on the
T-cell subsets required to trigger the reaction in the
mammalian adult GVHR model (Gleichman et al.,
1984; Korngold and Sprent, 1985; Sprent et al.,
1990). In this model, the GVHR usually develops in
an irradiated animal, whose own responding cells
.have been largely eradicated. On the other hand, in
the avian embryonic model,, host ceils proliferate
actively especially in the early phase of the reaction,
as shown earlier using sex chromosomes as markers
(Owen et al., 1965; Seto and Albright, 1965;
McBride, 1966; Nisbet and ’Simonsen, 1967). Preco-
cious immunological maturation of the host immune
system in serial transfer experiments was hypothes-
ized to occur under the influence of allogeneic cells
(McBride et al., 1966; Lafferty et al., 1972; Simonsen,
1985).
163164 FEDECKA-BRUNER et al.
In these studies however, subpopulations of host
and donor cells were not investigated for the want
of specific markers, so that the, enlarged spleen
remained largely a black box. We recently showed
by means of a pan T-cell monoclonal antibody
(mAb) (Yassine et al., 1989) that the T-cell popu-
lation became amplified by a factor of 10 or more in
the spleens of embryos undergoing a GVHR
(Fedecka-Bruner et al., 1989). For the present study,
we have used two inbred chicken strains, carrying,
respectively, the B4 and B12 MHC haplotypes, and
have performed double staining of spleen cells, to
combine detection of MHC haplotype and one of
several functional markers.
Panels of different monoclonal antibodies (mAbs)
specific for chicken cluster of differentiation (CD)
antigens have become available, allowing the study
of the expression of clonotypic (TCR1, equivalent of
mammalian y/TCR, Sowder et al., 1988; TCR2 a/
/J TCR, Chen et al., 1988) or invariant (CD3, Chen et
al., 1986) components of the CD3/TCR complex, as
well as the distribution of CD4, CD8 (Chan et al.,
1988), and IL-2-receptor (IL-2R) light chains (CD25,
Mr=50 kD, Hala et al., 1986; Schauenstein et al.,
1988). Using these mAbs in conjunction with allo-
antisera, we evaluated the relative contribution of
donor and recipient in an attempt to determine to
which extent specific and nonspecific phenomena
are involved in GVHR-induced splenomegaly.
RESULTS
Relative Contribution of Donor and Host Ceils to
Splenomegaly
As depicted in Fig. 1, the numeric contribution of
lymphoid cells increases in an overproportional
fashion during GVHR-induced splenomegaly (Figs.
1A and 1B). Among these lymphoid elements, a
significant portion exhibits allogeneic markers of the
donor MHC haplotype (B4) and appears to
vigorously proliferate in vivo, increasing by a factor
of 5.1 from E18 to 20 of embryonic age and reaching
up to 6.5 xl0 cells (Fig. 1C). Given that probably
only a fraction of the injected PBL (10 cells) homes
to the recipient’s spleen, the increase of donor cells
probably is more important than suggested by these
numbers. Nonetheless, the majority of cells (ap-
proximately 90% at E18 and 80% at E20) present in
the hyperplastic spleen (about 10 times control
weight at E18 to E20) is of host. origin. Thus, in situ
proliferation of recipient cells in the enlarging spleen
and/or recruitment of cells from other organs
quantitatively outnumber donor cells.
Characterization,of T-Lymphocyte Subpopulations
Splenomegaly produced in the (B4) donor-(B12)
recipient combination is accompanied by an increase
of CD8 + cells (from about 2 xl0 in controls to 5 xl0"
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FIGURE 1. Lymphoid cell numbers and donor-cell contribution in GVHR-induced splenomegaly. One million B or B12 lymphocytes (3-
to 4-week-old donors) were injected i.v. into E13 old B12 embryos. At E18, E19, or F.20 of embryonic age, splenic weight (A), total leuko-
cyte numbers (B), and the number of cells reacting with a B4)-specific alloantiserum (C) were determined. 86 + 2% of cells isolated from
spleens undergoing GVHR on E18 to E20 were stained by a B12-specific alloantiserum. Only E20 untreated (0) or syngeneic controls
(syng.) are shown; these control values do not significantly change from E18 to E20. Note the overproportional increase in lymphoid
cells and cells of the donor phenotype. Values were determined by microscope counting for (B) and by microscope counting and cell-
sorter analysis for (C).T SUBSETS IN GVHR SPLEEN 165
on E20 in embryos undergoing GVHR), as well as
by the appearance of cells that are practically absent
in control spleens, namely, lymphoid cells exhibiting
CD4, TCR1, TCR2, IL-2R, or a B-cell marker (Fig. 2).
From E18 to 20, the percentage of the CD8
/ cells
among splenocytes increases significantly, whereas
the percentages of other cell populations remain
relatively constant (although their absolute number
increases, Fig. 1). Nonetheless, the majority of
splenocytes isolated from chicken embryos under-
going GVHR lack surface antigens normally found
on lymphocytes. Thus, nonlymphoid or prelymphoid
(i.e., nonspecific) elements are important in the
generation of splenic hyperplasia. Double-staining
experiments reveal that CD4
/ cells are predomi-
nantly of the donor and CD8
/ cells of the recipient
MHC haplotype (Table 1). Though double staining
for CD4 or CD8 and TCR1 or TCR2 was not per-
formed, it is possible to infer from the values in
Table 1 that most CD4
/ cells (mainly of donor
origin) express TCR2. On the other hand, Fig. 2
shows that cells displaying TCR1 are scarce. It fol-
lows that most CD8
/ cells, the bulk of which origi-
nates from the recipient embryo, carry neither TCR1
nor TCR2. These CD8
/ cells thus probably cor-
respond to the cells found by Bucy et al. (1989,
1990) (CD4-CD8d""+TCR1-TCR2-TCR3-/surface
CD3-cytoplasmic CD3 /) that may represent the
avian equivalent of mammalian natural killer cells
(so-called TCR0 cells) and that develop in the un-
manipulated embryonic spleen independently of the
thymus.
Lymphocyte Subsets Expressing Interleukin-2-
Receptor Light Chains (CD25)
In untreated or syngeneic controls, CD25 is faintly
expressed only on a small (< 2%) subpopulation of
embryonic spleen cells. In contrast, up to 15% of
cells strongly express CD25 in spleens of chicks
undergoing GVHR. The majority of these CD25
/
cells bear the Class MHC recipient phenotype
(Table 1). Most CD8
/ cells (84%) and a large portion
of CD4
/ cells (65%) express CD25 on E20, that is, 7
days after injection of allogeneic adult PBL (Table 1).
These findings strongly suggest that IL-2-mediated
proliferation and/or differentiation are implicated in
the expansion of these cell subsets.
CONCLUDING REMARKS
The data shown in this paper suggest the following
scenario of GVHR-induced splenomegaly. After
intravenous injection, a portion of donor lympho-
cytes home to the embryonic spleen, where they are
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FIGURE 2. Lymphocyte subsets in GVHR-induced splenomegaly. Splenocytes (same animals
as in Fig. 1) were subjected to immunofluorescence analysis using a panel of monoclonal
antibodies. No significant difference was found-in lymphoid cell number and lymphocyte
subset distribution between E18 and E20 syngeneic controls (E20 values shown). The percen-
tage of B cells (open bars) were only determined for E20. Cell counts were determined by
microscope examination and Facs analysis.166 FEDECKA-BRUNER et al.
TABLE1 1988). The unphysiological presence of activated
Assignation of Lymphocyte Subsets to the Donor (B4) or host (B12) CD4 donor cells and/or activation of recipient MHC Haplotype and Characterization of Cells Expressing the
Subpopulation
IL2-R Light Chain (CD25)
Percentage of cells positive among respective
subpopulations for
B4 B12 CD25
All lymphoid cells 19.6 4. 0.2 77.4 +__ 3.5 13.2 + 1.1
CD4 91.7 + 0.8 5.6 4. 0.4 66.8 + 5.0
CD8 22.5 + 0.5 76.5 + 3.5 83.9 4- 8.2
TCR1 ND ND 100
TCR2 87.5 4- 2.5 14.0 4- 2.1 71.1 4-13.6
CD25 22 4- 6 77 + 7 100
B 100 37.5 4- 5.8
B12 100 62.5 4- 6.4
lymphocytes in the spleen undergoing GVHR prob-
ably also stimulate the nonspecific proliferation of
hematolymphopoietic elements. Thus, the prolifera-
tion of donor lymphocytes is outnumbered by the
expansion and/or recruitment of host cells either of
lymphoid (TCR0), prelymphoid or nonlymphoid
type. Experiments about local GVHR also detected a
predominance of host cells over cells expressing the
donor MHC haplotype in chlorioallantoic pocks
(Penninger et al., 1989, 1990).
To summarize, the data reported here point to a
significant donor as well as host contribution to
qF double staining followed by microscope counting and cell-sorter GVHR in the chicken embryo and reveal the exist- analysis were applied to splenocytes from E20 embryos undergoing
GVHR. ence of specific and nonspecific components in
bND=ntdetermined" splenomegaly development. It should indeed be
emphasized that about 80% of white blood cells
activated and start proliferating in response to present in the enlarged spleens do not seem to
allogeneic antigens, mainly MHC determinants, once belong to the lymphoid population. The embryo
they become expressed during ontogeny. Because challenged with an IL-2 stimulation appears to
the expression of Class II MHC antigen precedes respond by amplifying the cell types present at that
that of Class I, the latter being detectable only time, that is, CD8+ cells and cells that are probably
shortly before hatching (Kroemer et al., 1990), hemopoietic precursors. It remains to be investi-
predominantly CD4
/ (i.e., Class II-restricted) T cells gated whether proliferating cells display the same
are activated. These CD4
/ ("helper")lymphocytes of subpopulation profile, when GVHR occurs in neo-
donor origin express the high affinity IL-2R and natal rather than embryonic hosts or in adult organ-
probably produce their own IL-2 and proliferate in isms made immunodeficient by artificial means.
an autocrine fashion via the IL-2/IL-2R pathway, as
do mammalian CD4
/ cells of the TH0 or TH1 pheno-
type (Smith, 1988). At the same period, CD8/TCR0 MATERIALS AND METHODS cells of the recipient become activated either by the
antigenic makeup of the donor-cell population or Induction and Quantitation of GVHR
more likely by the presence of T helper-derived
lymphokines. CD8
/ cells have been described by Highly inbred chickens homozygous for either the
Max Cooper’s group in the embryonic and adult B (CC line) or B12 (CB line) MHC haplotypes
chicken (Bucy et al., 1989, 1990). No TCR has been (obtained from the Czechoslovakian Academy of
found on these cells, which have been interpreted as Sciences, Prague, or from the INRA station in Le
candidate natural killer cells in this species. Practi- Magneraud, France) were used in all experiments.
cally all CD8/TCR0 cells in the GVHR spleen dis- 106 peripheral blood lymphocytes (PBL) were iso-
play the IL-2R, thus being capable of proliferating in lated from heparinized blood from 3- to 4-week-old
response to endogenous or exogenous IL-2. In sup- donors by differential centrifugation, washed in
port of a central role of IL-2 in the pathogenesis of phosphate-buffered saline (PBS, pH 7.2), and
splenomegaly, local as well as systemic GVHR of injected into a chorioallantoic vein of 13-day-old
mice or humans are suppressed by monoclonal (E13) syngeneic or allogeneic embryos. Necropsy
antibodies directed against the IL-2R (Ferrara et al., was performed after 5, 6, or 7 more days of incuba-
1986; Volk et al., 1986; Cavazzana-Calvo et al., tion (E18 to E20).
1990). Similarly, local GVHR in the chicken embryo
can be prevented by functional IL-2R blockade with Cytofluorochemical Analysis INN-CH-16 (Penninger et al., 1989), that is, a
murine mAb that neither binds chicken complement After mechanical dissociation of the embryonic
nor exerts direct toxic effects (Schauenstein et al., spleen through 200-mesh stainless steel sieves,T SUBSETS IN GVHR SPLEEN 167
viable cells (initially, >70%) were purified by
means of a FicollR (Pharmacia, Uppsala, Sweden)
gradient, washed in PBS supplemented with 10%
heat-inactivated bovine serum, and subjected to
immunofluorescence analysis. 1 x106 cells/ml were
incubated in a first step, either with biotinylated B
or Bla-specific alloantisera (gift from Dr. D. Bouret)
or with the monoclonal antibodies (mAbs) CT4
(specific for CD4, Chan et al., 1988), CT8 (CD8,
Chan et al., 1988), TCR1 (y/ TCR, Sowder et al.,
1988; kindly, provided by Dr. Max Cooper), TCR2
(c//J TCR, Chen et al., 1988; gift from Dr. Cihak),
319D-3 (specific for B cells; gift from Dr. F.
Coudert), or INN-CH-16 (directed against the in-
ducible light chain of the IL-2 receptor, CD25; Hala
et al. (1986; obtained from Dr. Karel Hala), which
were used at optimal concentrations established in
preliminary experiments. After three washes (600 xg,
5 min, 4C), fluorescence was developed using either
streptavidin-phycoerythrin conjugates (Southern
Biotechnology, Birmingham, AL), antimouse pan Ig-
FITC (Nordic, Tilburg, Netherlands) or phyco-
erythrin, antimouse IgM texas red (Southern, for
INN-CH-16), or antimouse IgG1-FITC (Southern, for
all other monoclonal antibodies). All incubations
were performed on wet ice for 30 min, followed by
three washes. Stained cells were analyzed using
automated cytofluorometry (FACS IV, Becton-
Dickinson) or examined visually by fluorescence
microscopy. For each value presented
(mean+ standard error of the mean, SEM) three to
eight experimental series (each comprising two to
five animals) were performed. Group differences
were calculated using the Mann-Whitney test.
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